Aller au contenu principal
2024 conference-abstract

Abstract P435: PROTEIN KINASE MODULATION IN THE INVESTIGATION OF ANGIOTENSIN-CONVERTING ENZYME AS A SIGNALING PATHWAY.

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : br. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

The Renin-Angiotensin System (RAS) is a hormonal cascade intricately involved in regulating hydro electrolyte homeostasis and blood pressure control. The Angiotensin II peptide (ANGII) is the main and most potent biologically active product within this system, which is produced by the action of Angiotensin Converting Enzyme (ACE) on Angiotensin I. Dysregulation of the RAS is an important factor in the pathogenesis and progression of cardiovascular diseases and diabetes. Furthermore, ACE inhibitors (iECA) havebeen associated with the activation of signaling pathways, thus implicating ACE as a signal transducer molecule. This study aims to elucidate the significance of signaling pathways triggered by ACE and proteins that are differentially regulated when CHO-ECA cells are stimulated with ACE inhibitors. At approximately 80% confluency, the cells were deprived of serum and then stimulated with captopril (1μM) or enalapril (1μM) or vehicle for 2 and 5 minutes (n=10 in each group), to discerning the influence of sulfhydryl and carboxyl radicals. CHO-ECA cells were cultured for Kinase Array assay analysis using the Phospho-kinase Array Kit. This assay demonstrated that some pathways were positively modulated after captopril treatment after 2 minutes (AMPKa1, HSP27, Akt 1/2/3 T308) and after 5 (STATa/b, HSP60, b-Catenin). Some kinases were negatively modulated by captopril treatment (p53, PLC-γ1, Pyk2, eNOS). Conversely, treatment with enalapril modulated proteins differently at both treatment times. Some phospho-protein kinases were positively modulated in 2 minutes, such as PLC γ1, PYK2, and Yes, and others were positively modulated in 5 minutes (EGFR, GSK-3α/β, Lyn, PDGF Rβ, STAT 5a/b, WNK1 and STAT3 S2). The kinases AKT 1/2/3 T308, AKT 1/2/3 S743, CREB, Chk-2, c-Jun, JNK1/2/3, Lck, p38α, STAT3 Y705, β-Catenin were positively modulated in 2 and 5 minutes. The kinases eNOS, ERK1/2, GSK-3β, HSP27, p53 S15, p53 S46, MSK1/2, p70 S6 T389, p70 S6 T421/S424, PRAS40, Src, RSK1/2, RSK1/2/3, STAT1 and HSP60 were negatively modulated at 2 and 5 minutes. In conclusion, our findings augmented the current understanding of kinases modulated by captopril or enalapril, after ACE binding, highlighting the multifaceted role of ACE. Therefore, it can suggest that ACE may be a candidate to act not only as an enzyme but also as a signaling receptor and transducer protein.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Abstract P435: PROTEIN KINASE MODULATION IN THE INVESTIGATION OF ANGIOTENSIN-CONVERTING ENZYME AS A SIGNALING PATHWAY.
Date Crossref
01/09/2024
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Universidade Federal de São Paulo pays non établi dans la notice
    Université ou école supérieure

Universidade Federal de São Paulo.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Cell Adhesion Molecules ResearchRadiopharmaceutical Chemistry and Applications

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.